Testing effectiveness (Phase 2)Ended earlyNCT00177255What this trial is testingDocetaxel in Combination With Capecitabine in Stomach and Esophagus CancersWho this might be right forCancer University of Pittsburgh 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06469060What this trial is testingNeoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric JunctionWho this might be right forEsophageal Cancer Shanghai Chest Hospital 34
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05480384What this trial is testingAdjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal JunctionWho this might be right forEsophageal AdenocarcinomaEsophageal CancerHER-2 Protein Overexpression+1 more Brown University 1
Large-scale testing (Phase 3)Ended earlyNCT02551458What this trial is testingComparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to RadiochemotherapyWho this might be right forEpidermoid Carcinoma orAdenocarcinoma of the Thoracic Oesophagus orAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)+1 more Centre Hospitalier Universitaire Dijon 188
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37
Not applicableLooking for participantsNCT07675967What this trial is testingClonal Hematopoiesis Chemotherapy and Radiation Effects StudyWho this might be right forLung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more Dana-Farber Cancer Institute 5,000
Large-scale testing (Phase 3)UnknownNCT04385550What this trial is testingAnlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction AdenocarcinomaWho this might be right forAdvanced Gastric and Gastro-oesophageal Junction Adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 528
Early research (Phase 1)Study completedNCT01561014What this trial is testingOxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more Wake Forest University Health Sciences 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04704934What this trial is testingTrastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Who this might be right forGastric Cancer, AdenocarcinomaGastroesophageal Junction Adenocarcinoma Daiichi Sankyo 490
Testing effectiveness (Phase 2)UnknownNCT03139487What this trial is testingPhase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismWho this might be right forCancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more Asan Medical Center 176
Testing effectiveness (Phase 2)Study completedNCT05007106What this trial is testingMK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)Who this might be right forUterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more Merck Sharp & Dohme LLC 613
Not applicableStudy completedNCT00795184What this trial is testingDetection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal EndomicroscopyWho this might be right forBarrett SyndromeBarrett's SyndromeBarrett's Esophagus+2 more Mauna Kea Technologies 122
Testing effectiveness (Phase 2)Study completedNCT00217087What this trial is testingEndoscopic Therapy of Early Cancer in Barretts EsophagusWho this might be right forEarly Stage Esophageal AdenocarcinomaBarrett Esophagus Mayo Clinic 73
Testing effectiveness (Phase 2)Ended earlyNCT01307956What this trial is testingPanitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal AdenocarcinomaStage IIA Esophageal Cancer+1 more University of Nebraska 11
Testing effectiveness (Phase 2)Looking for participantsNCT06687876What this trial is testingMetformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant ChemoradiotherapyWho this might be right forOesophageal AdenocarcinomaTumor Microenvironment Amsterdam UMC, location VUmc 14
Testing effectiveness (Phase 2)Study completedNCT03777813What this trial is testingAssociation of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcerWho this might be right forEsophagus CancerUnresectable Malignant Neoplasm UNICANCER 112
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Ended earlyNCT00216008What this trial is testingPharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.Who this might be right forEsophageal AdenocarcinomasAdenocarcinomas of the Gastroesophageal Junction H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94